Dawn of New Lupus Nephritis Treatment After AURORA Trial Dawn of New Lupus Nephritis Treatment After AURORA Trial

The addition of a novel calcineurin inhibitor to the standard of care improves renal response in patients with lupus nephritis, results from the phase 3 AURORA trial show.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news